Tandem Diabetes Care Inc.

NASDAQ: TNDM · Real-Time Price · USD
10.86
0.20 (1.88%)
At close: Aug 15, 2025, 1:14 PM

Tandem Diabetes Care Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
940.2M 747.72M 801.22M 702.8M
Cost of Revenue
450.63M 380.03M 388.23M 326.58M
Gross Profit
489.57M 367.69M 412.99M 376.21M
Operating Income
-99.13M -233.23M -61.81M 8.81M
Interest Income
17.99M 22.86M 6.06M 674K
Pretax Income
-91.87M -220.25M -92.85M 15.9M
Net Income
-96.03M -222.61M -94.59M 15.57M
Selling & General & Admin
389.82M 352.5M 335.68M 261.51M
Research & Development
198.88M 169.67M 139.11M 92.05M
Other Expenses
n/a 78.75M -4K n/a
Operating Expenses
588.7M 600.92M 474.8M 353.56M
Interest Expense
7.42M 9.88M 6.21M 6.04M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
1.04B 980.95M 863.03M 680.15M
Income Tax Expense
4.16M 2.36M 1.74M 335K
Shares Outstanding (Basic)
65.45M 64.9M 64.15M 63M
Shares Outstanding (Diluted)
65.45M 64.97M 64.15M 64.35M
EPS (Basic)
-1.47 -3.43 -1.47 0.25
EPS (Diluted)
-1.47 -3.43 -1.47 0.24
EBITDA
-99.13M -194.66M -72.31M 36.5M
EBIT
-99.28M -212.69M -88.54M 20.21M
Depreciation & Amortization
158K 15.71M 14.33M 13.85M